Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henry, T. R.
Right arrow Articles by Kuhl, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henry, T. R.
Right arrow Articles by Kuhl, D. E.
NEUROLOGY 1993;43:1998
© 1993 American Academy of Neurology

In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy

T. R. Henry, MD, K. A. Frey, MD, PhD, J. C. Sackellares, MD, S. Gilman, MD, R. A. Koeppe, PhD, J. A. Brunberg, MD, D. A. Ross, MD, S. Berent, PhD, A. B. Young, MD, PhD and D. E. Kuhl, MD

From the Departments of Neurology (Drs. Henry, Frey, Sackellares, Gilman, Brunberg, Berent, and Young), Internal Medicine (Drs. Frey, Koeppe, and Kuhl), Radiology (Drs. Brunberg and Kuhl), Surgery (Drs. Brunberg and Ross), and Psychiatry (Dr. Berent), University of Michigan Medical Center, Ann Arbor, MI.

Positron emission tomography measured interictal cerebral glucose metabolism with [18F]fluorodeoxyglucose and central benzodiazepine-receptor binding with [11C]flumazenil in 10 mesial temporal lobe epilepsy (TLE) patients and in normal subjects. Eight TLE patients had mesial temporal, lateral temporal, and thalamic hypometabolism ipsilateral to EEG ictal onsets, with additional extratemporal hypometabolism in four. One had unilateral anterior mesial temporal hypometabolism only, and one had normal metabolism. Each patient had decreased benzodiazepine-receptor binding in the ipsilateral anterior mesial temporal region, without neocortical changes. Thus, interictal metabolic dysfunction is variable and usually extensive in TLE, whereas decreased central benzodiazepine-receptor density is more restricted to mesial temporal areas. Metabolic patterns in TLE may reflect diaschisis, while benzodiazepine-receptor changes may reflect localized neuronal and synaptic loss that is specific to the epileptogenic zone. [11C]Flumazenil imaging maybe useful in presurgical evaluation of refractory complex partial seizures.

Address correspondence and reprint requests to Dr. J. Chris Sackellares, Department of Neurology, University of Michigan Medical Center, North Ingalls Building 3D06, 400 N. Ingalls, Ann Arbor, MI 48109.

Supported in part by the National Institutes of Health (N1NDS-P01 NS15655).

Received January 7, 1993. Accepted for publication in final form March 11, 1993.




This article has been cited by other articles:


Home page
BrainHome page
S. Bouvard, N. Costes, F. Bonnefoi, F. Lavenne, F. Mauguiere, J. Delforge, and P. Ryvlin
Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study
Brain, June 1, 2005; 128(6): 1330 - 1343.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. K. Lee, C. H. Yun, J. B. Oh, H. W. Nam, S. W. Jung, J. C. Paeng, D. S. Lee, C. K. Chung, and G. Choe
Intracranial ictal onset zone in nonlesional lateral temporal lobe epilepsy on scalp ictal EEG
Neurology, September 23, 2003; 61(6): 757 - 764.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, M. P. Richardson, R. Hurlemann, D. J. Brooks, and J. S. Duncan
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients
Brain, June 1, 2003; 126(6): 1300 - 1318.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, R. Hurlemann, M. Thom, M. P. Richardson, D. J. Brooks, and J. S. Duncan
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI
Brain, October 1, 2002; 125(10): 2257 - 2271.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, M. P. Richardson, C. Labbe, D. J. Brooks, V. J. Cunningham, and J. S. Duncan
Central benzodiazepine receptors in malformations of cortical development: A quantitative study
Brain, August 1, 2001; 124(8): 1555 - 1565.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Hammers, M.J. Koepp, C. Labbe, D.J. Brooks, M. Thom, V.J. Cunningham, and J.S. Duncan
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy
Neurology, April 10, 2001; 56(7): 897 - 906.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Juhasz, D. C. Chugani, O. Muzik, C. Watson, J. Shah, A. Shah, and H. T. Chugani
Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy
Neurology, September 26, 2000; 55(6): 825 - 835.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Lamusuo, A. Pitkanen, L. Jutila, A. Ylinen, K. Partanen, R. Kalviainen, H.-M. Ruottinen, V. Oikonen, K. Nagren, P. Lehikoinen, et al.
[11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology
Neurology, June 27, 2000; 54(12): 2252 - 2260.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Koutroumanidis, M. J. Hennessy, P. T. Seed, R. D. C. Elwes, J. Jarosz, R. G. Morris, M. N. Maisey, C. D. Binnie, and C. E. Polkey
Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy
Neurology, May 9, 2000; 54(9): 1811 - 1821.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Koepp, A. Hammers, C. Labbe, F. G. Woermann, D. J. Brooks, and J. S. Duncan
11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI
Neurology, January 25, 2000; 54(2): 332 - 332.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. Muzik, E. A. da Silva, C. Juhasz, D. C. Chugani, J. Shah, F. Nagy, A. Canady, H.-M. von Stockhausen, K. Herholz, J. Gates, et al.
Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy
Neurology, January 11, 2000; 54(1): 171 - 171.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Juhasz, F. Nagy, C. Watson, E. A. da Silva, O. Muzik, D. C. Chugani, J. Shah, and H. T. Chugani
Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy
Neurology, December 1, 1999; 53(9): 2037 - 2037.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. A. Gross and W. H. Theodore
""The seat of the discharge"" and the molecules that govern seizures
Neurology, February 1, 1999; 52(3): 441 - 441.
[Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J. S DUNCAN
Interictal focal activity in temporal lobe epilepsy
J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 149 - 149.
[Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M. Koutroumanidis, C. D Binnie, R. D C Elwes, C. E Polkey, P. Seed, G. Alarcon, T. Cox, S. Barrington, P. Marsden, M. N Maisey, et al.
Interictal regional slow activity in temporal lobe epilepsy correlates with lateral temporal hypometabolism as imaged with 18FDG PET: neurophysiological and metabolic implications
J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 170 - 176.
[Abstract] [Full Text]


Home page
StrokeHome page
W.-D. Heiss, R. Graf, T. Fujita, K. Ohta, B. Bauer, J. Lottgen, and K. Wienhard
Early Detection of Irreversibly Damaged Ischemic Tissue by Flumazenil Positron Emission Tomography in Cats
Stroke, October 1, 1997; 28(10): 2045 - 2052.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
A.L. Malizia and M.P. Richardson
Benzodiazepine receptors and positron emission tomography: ten years of experience. A new beginning?
J Psychopharmacol, January 1, 1995; 9(4): 355 - 368.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.